Abstract:Emerging evidence suggests that chronic exposure to aristolochic acids (AAs) is one of the etiological pathways leading to chronic kidney disease (CKD). Due to the traditional practice of herbal medicine and AA-containing plants being used extensively as medicinal herbs, over 100 million East Asians are estimated to be at risk of AA poisoning. Given that the chronic nephrotoxicity of AAs only manifests itself after decades of exposure, early diagnosis of AA exposure could allow for timely intervention and disease risk reduction. However, an early detection method is not yet available, and diagnosis can only be established at the end stage of CKD. The goal of this study was to develop a highly sensitive and selective method to quantitate protein adducts of aristolochic acid I (AAI) as a biomarker of AA exposure. The method entails the release of protein-bound aristolactam I (ALI) by heat-assisted alkaline hydrolysis, extraction of ALI, addition of internal standard, and quantitation by liquid chromatography-tandem mass spectrometric analysis. Accuracy and precision of the method were critically evaluated using a synthetic ALI-containing glutathione adduct. The validated method was subsequently used to detect dose-dependent formation of ALI-protein adducts in human serum albumin exposed to AAI and in proteins isolated from the tissues and sera of AAI-exposed rats. Our time-dependent study showed that ALI-protein adducts remained detectable in rats even at 28 days postdosing. It is anticipated that the developed method will fill the technical gap in diagnosing AA intoxication and facilitate the biomonitoring of human exposures to AAs.

Interaction studies of aristolochic acid I with human serum albumin and the binding site of aristolochic acid I in subdomain IIA.

Evaluation of Molecular Binding Modes on Site Ii of Human Serum Albumin

Study on the Interaction between Aristolochic Acid and Human Serum Albumin by Spectrofluorimetry

[Research on the Interaction of Aristolochic Acid and Bovine Serum Albumin].

Characterization of Alizarin Red S binding sites and structural changes on human serum albumin: a biophysical study.

Study on the interaction between human serum albumin and a novel bioactive acridine derivative using optical spectroscopy.

Characterizing the Binding Interaction of Astilbin with Bovine Serum Albumin: a Spectroscopic Study in Combination with Molecular Docking Technology.

The Interaction between Arctiin of Active Constituent of Medical Plant and Human Serum Albumin

Protein-docking strategy boosting Raman detection sensitivity for aristolochic acid I

Studies on the interaction between Ag+ and human serum albumin

Molecular Docking and Spectroscopic Methods to Probe the Interaction of Acetylgliotoxin and HSA

The Interaction Between 4-Aminoantipyrine and Bovine Serum Albumin: Multiple Spectroscopic and Molecular Docking Investigations

Structural analysis and binding domain of albumin complexes with natural dietary supplement humic acid

Binding Mechanism and Molecular Docking between Aflatoxin G1 and Human Serum Albumin

Probing the intermolecular interactions into serum albumin and anthraquinone systems: a spectroscopic and docking approach

Human Serum Albumin Stability and Toxicity of Anthraquinone Dye Alizarin Complexone: an Albumin-Dye Model

Quantitation of Protein Adducts of Aristolochic Acid I by Liquid Chromatography-Tandem Mass Spectrometry: A Novel Method for Biomonitoring Aristolochic Acid Exposure.

Localization of aristolochic acid in mouse kidney tissues by immunohistochemistry using an anti-AA-I and AA-II monoclonal antibody.

Spectroscopic studies on the interaction of cinnamic acid and its hydroxyl derivatives with human serum albumin

Characterization of the Interaction Between Acotiamide Hydrochloride and Human Serum Albumin: 1H STD NMR Spectroscopy, Electrochemical Measurement, and Docking Investigations

Complexes Between C.I. Acid Orange 6 and Human Serum Albumin, a Multi-Spectroscopic Approach to Investigate the Binding Behavior